54
Views
0
CrossRef citations to date
0
Altmetric
Letter

Mild cognitive decline in type 2 diabetes mellitus patients – risk factors and pathogenesis: role of DPP4 activity and future possible therapeutic targets

&
Pages 403-404 | Published online: 04 Feb 2019

References

  • AlbaiOFrandesMTimarRRomanDTimarBRisk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairmentNeuropsychiatr Dis Treat20191516717530655669
  • ZhengTQinLChenBAssociation of plasma DPP4 activity with mild cognitive impairment in elderly patients with type 2 diabetes: results from the GDMD study in ChinaDiabetes Care20163991594160127371673
  • ZhengTLiuHQinLOxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in ChinaMetabolism20188710511229572131
  • PintanaHApaijaiNChattipakornNChattipakornSCDPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant ratsJ Endocrinol2013218111123591914
  • MaMHasegawaYKoibuchiNDPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic miceCardiovasc Diabetol20151415425986579